HHS Selects Drugs for Medicare Price Negotiation
Biden Administration introduces price regulation to the pharmaceutical industry.
Supreme Court To Hear Case Endangering the Chevron Doctrine
A dispute over fishery regulation could deliver a blow to a key doctrine calling for deference to administrative agencies.
Stamping Out Counterfeit Postage
The U.S. Postal Service adopts final rule aimed at reducing postage fraud.
Clamping Down on Commercial Spyware
Biden Administration issues executive order prohibiting federal contracts with spyware firms.
Celebrating Our 2022-2023 Editorial Board
Congratulations and thank you to The Regulatory Review’s 2022-2023 Editorial Board.
On Anti-ESG Resolution, Biden Issues First Veto
The President’s veto keeps in place a retirement investment rule allowing fiduciaries to consider ESG factors.
Improving Public Engagement in the Regulatory Process
Biden Administration seeks feedback from the public on how to expand participation in the regulatory process.
Regulators Propose Updates to Community Reinvestment Act Rules
Financial regulators propose new rules to expand and modernize law that targets inequities in bank lending.
CFPB Targets Illegal Junk Fees
New CFPB guidance puts banks on notice that unfair business practices may be met with enforcement action.
Changes to ERISA Open Door to ESG Investments
ERISA fiduciaries may now consider ESG in investment decision making.